Added to YB: 2022-10-07
Pitch date: 2022-10-07
MREO [bullish]
Mereo BioPharma Group plc
+112.12%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
Market Cap
$281.6M
Pitch Price
$0.99
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.22
P/E
-5.60
EV/Sales
452.15
Sector
Biotechnology
Category
N/A
Mereo BioPharma: Activist Proxy Fight
MREO: $100MM mkt cap, $105MM cash. Activist Rubric (14% owner) seeks board control to monetize assets. Valuation suggests 2x upside. Key asset: Setrusumab partnership with RARE for OI. AZN rumored bid at $5/share ($500MM). Special meeting in Nov for board reconstitution. Risks: biotech sector, valuation uncertainty.
Read full article (1 min)